EP Patent

EP2596112A1 — Acetycysteine compositions and methods of use thereof

Assigned to Cumberland Pharmaceuticals Inc · Expires 2013-05-29 · 13y expired

What this patent protects

A pharmaceutical composition and method for providing a reduction in side effects for human patients in need of therapy comprising the administration of a pharmaceutical composition comprising acetylcysteine is disclosed.

USPTO Abstract

A pharmaceutical composition and method for providing a reduction in side effects for human patients in need of therapy comprising the administration of a pharmaceutical composition comprising acetylcysteine is disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP2596112A1
Jurisdiction
EP
Classification
—
Expires
2013-05-29
Drug substance claim
No
Drug product claim
No
Assignee
Cumberland Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.